Ceramide-Containing Cosmetics OEM Development Guide | Ingredient Selection, Formulation Design & Differentiation Strategy

Ceramide is a sphingolipid that accounts for approximately 50% of the intercellular lipids in the stratum corneum and plays a central role in the skin's barrier function and moisture retention. Reduced ceramide levels are considered a primary factor in atopic dermatitis and dry skin, and ceramide-containing cosmetics—supported by dermatological evidence—continue to expand as a high-performance skincare market segment.

Ceramides used in cosmetics are broadly classified into three categories.

1. Human-type ceramides (human-identical ceramides)

These have the same chemical structure as the ceramides found in the human stratum corneum. The INCI names and their former designations are as follows:

• Ceramide EOP (INCI: Ceramide EOP, formerly Ceramide 1): A type of acylceramide. Essential for the formation of long-period lamellar structures in the stratum corneum, and considered to have the greatest contribution to barrier function.
• Ceramide NS (INCI: Ceramide NS, formerly Ceramide 2): The most abundant ceramide in the stratum corneum. Provides strong moisturizing effects and has the most extensive formulation track record.
• Ceramide NP (INCI: Ceramide NP, formerly Ceramide 3): The second most abundant ceramide. Numerous reports document its barrier function recovery effects. Improvement of fine lines caused by dryness has also been suggested.
• Ceramide AP (INCI: Ceramide AP, formerly Ceramide 6II): Believed to be involved in promoting stratum corneum turnover, with expected effects on skin roughness improvement.
• Ceramide AG (INCI: Ceramide AG, formerly Ceramide 5): Plays a complementary role in barrier function when combined with other ceramides.

2. Plant ceramides (glucosylceramides)

Glucosylceramides (INCI: Glucosylceramide) extracted from rice, konjac, pineapple, beet, etc. While structurally different from human-type ceramides, oral intake has been reported to increase stratum corneum ceramide levels, attracting attention for inner beauty products. For topical cosmetic use, the direct barrier function recovery effect is considered more limited compared to human-type ceramides.

3. Synthetic pseudo-ceramides

Representative examples include cetyl PG hydroxyethyl palmitamide (INCI: Cetyl PG Hydroxyethyl Palmitamide). This pseudo-ceramide, developed by Kao Corporation, is less expensive than human-type ceramides and can be mass-produced. It is used in Kao's Curel series, among other products.

In ceramide cosmetics OEM development, raw material supplier selection is a critical decision that affects formulation quality and cost. Here is an overview of major ceramide raw material suppliers and their characteristics.

Evonik (formerly Goldschmidt)

• Products: CERAMIDE NP (SK-INFLUX V), CERAMIDE AP, CERAMIDE EOP
• Features: High-purity human-type ceramides produced by chemical synthesis. Pharmaceutical-grade quality management. The most extensive global adoption track record.
• Price range: Approximately ¥100,000–150,000 (approx. $670–1,000) per kg for Ceramide NP. Minimum purchase from 100 g.
• SK-INFLUX V (a premix containing Ceramide NP, cholesterol, phytosphingosine, and cetyl palmitate) is widely used as a formulation-ready premix that facilitates lamellar structure formation.

Takasago International Corporation

• Product: CERAMELA (fermented ceramide)
• Features: Bioceramide produced by fermenting plant-based raw materials using yeast (Wickerhamomyces ciferrii). Excellent sustainability and storytelling appeal; attracting attention in the natural cosmetics and clean beauty markets.
• Supply format: Supplied as a mixture of Ceramide NS/NP/AP. High natural origin ratio is a key differentiator.

Kao Corporation

• Has extensive formulation experience through its own brands Sofina and Curel. Developer of the pseudo-ceramide (cetyl PG hydroxyethyl palmitamide).
• OEM raw material supply is limited, but pseudo-ceramides can also be sourced from other suppliers.

Daicel Corporation

• Products: Ceramide TIC Series
• Features: Chemically synthesized human-type ceramides available in multiple grades. Wide lineup from high-purity products to cost-optimized standard grades. Extensive adoption record among OEM manufacturers in Japan.

Unitika Ltd.

• Product: Ceramela (rice-derived glucosylceramide)
• Features: Plant ceramide derived from Japanese rice. Can be leveraged for cross-product campaigns linking inner beauty supplements (ingestible ceramide + topical ceramide).

In OEM development, obtain technical data sheets and stability data from raw material suppliers to select the appropriate grade for your target formulation. Ideally, conduct trial formulations with materials from multiple suppliers and compare stability and sensory performance.

Ceramide is one of the most challenging ingredients to formulate in cosmetics. Here are the main technical challenges and their solutions.

Challenge 1: Ceramide crystallization

Ceramides have high melting points (Ceramide NP melts at approximately 130°C) and are extremely crystalline solids at room temperature. Simply dissolving them in the oil phase and emulsifying will result in crystals precipitating over time, causing a gritty texture degradation and turbidity or sedimentation in appearance. Approaches to prevent crystallization include:

• Co-formulation with cholesterol and fatty acids: Mimicking the composition of stratum corneum intercellular lipids by formulating ceramide : cholesterol : free fatty acid at a molar ratio of 1:1:1 to 3:1:1 suppresses crystallization while promoting lamellar liquid crystal structure formation.
• Addition of phytosphingosine: Adding 0.1–0.5% of phytosphingosine (INCI: Phytosphingosine), a ceramide precursor, disrupts the crystal packing of ceramide molecules and promotes stable lamellar structure formation.
• Dissolution temperature management: Heating the oil phase to 80–90°C to completely dissolve the ceramide, then emulsifying during gradual cooling, controls crystal nucleus formation. Rapid cooling should be avoided as it promotes microcrystal precipitation.

Challenge 2: Lamellar structure formation

Forming lamellar liquid crystal structures within the formulation that mimic the stratum corneum barrier function is the key to maximizing the efficacy of ceramide-containing cosmetics. Using hydrogenated lecithin (Hydrogenated Lecithin) as the emulsifier and combining it with ceramide, cholesterol, and fatty acids creates multilamellar vesicles (MLV) within the emulsion. Observation under a polarized light microscope reveals Maltese cross patterns, which serve as indicators of lamellar structure formation.

Challenge 3: Liposome encapsulation

This technology encapsulates ceramide in liposomes (particle size 50–200 nm) formed from phospholipid bilayer membranes. It further improves ceramide skin penetration while facilitating dispersion in aqueous systems. Manufacturing methods include the Bangham method (thin-film hydration) and extrusion, with sizing via high-pressure homogenizer to achieve uniform particle size. Liposome-encapsulated ceramide has higher manufacturing costs (1.5–2 times normal formulations) but serves as an effective differentiation element for premium product lines.

Concentration optimization and stabilization methods in ceramide cosmetics formulation design are decisive factors for product quality and efficacy.

Recommended concentration guidelines

• Ceramide NP: 0.1–0.5% (by weight). Below 0.05%, efficacy is difficult for users to perceive; above 0.5%, crystallization risk and raw material costs increase sharply. For skincare creams, 0.2–0.3% offers the best balance of quality and cost.
• Ceramide NS: 0.05–0.3%. Has a lower melting point than NP, resulting in relatively good formulation stability.
• Ceramide AP: 0.05–0.2%. Synergistic effects are expected when combined with NP and NS.
• Ceramide EOP: 0.01–0.1%. Typically formulated at low concentrations due to high cost, but has a significant contribution to lamellar structure formation.
• Multi-type formulations: A design such as Ceramide NP 0.15% + NS 0.1% + AP 0.05% + EOP 0.02% (total 0.32%) has strong marketing appeal as "4 types of human-type ceramides" while maintaining formulation stability.

Co-formulation components and optimal ratios required for stabilization

As noted above, using ceramide alone carries a high risk of crystallization, so co-formulation with the following components at appropriate ratios is essential.

• Cholesterol (INCI: Cholesterol): Equimolar to ceramide (approximately 0.7x by weight). Adjusts lamellar liquid crystal fluidity and suppresses crystallization.
• Free fatty acids: Palmitic acid (INCI: Palmitic Acid) or stearic acid (INCI: Stearic Acid) at 1–3x molar ratio relative to ceramide. Optimizes lamellar structure packing.
• Phytosphingosine (INCI: Phytosphingosine): 0.1–0.3%. Also has antimicrobial properties, functioning as a preservative system supplement.
• Hydrogenated Lecithin (INCI: Hydrogenated Lecithin): 0.5–2.0%. Used as the primary emulsifier for lamellar structure formation.

These component ratios align closely with the design philosophy of Evonik's SK-INFLUX V premix, and using the premix offers the advantage of eliminating the need for manual ratio optimization. For final confirmation of formulation stability, use polarized light microscopy to verify the absence of ceramide crystal precipitation after 6 months of accelerated stability testing at 40°C.

Efficacy evaluation of ceramide-containing cosmetics is conducted through objective measurement of barrier function and moisturizing function. Below are the main testing methods for reference when determining evaluation criteria with an OEM manufacturer.

1. TEWL (Transepidermal Water Loss) measurement

TEWL is the most important metric for quantitatively evaluating skin barrier function. It measures the amount of water evaporating from the skin surface in g/m²/h. The Tewameter TM300 by Courage+Khazaka is the industry-standard measurement device. The TEWL reduction rate before and after using a ceramide product is calculated to quantify barrier function improvement.

• Measurement conditions: Conducted in a constant temperature/humidity room at 20–22°C and 40–60% humidity. The inner forearm is the measurement site; for continuous-use studies, a 2–4 week usage period is set.
• Significance threshold: A TEWL reduction rate of 15–30% supports a "barrier function improvement" claim. Multiple studies have reported 20–25% TEWL reduction after 2 weeks of continuous use of cream containing 0.2% human-type ceramide.

2. Stratum corneum moisture content measurement

Stratum corneum moisture content is measured using the electrical capacitance method (Corneometer CM825, Courage+Khazaka). An increase in stratum corneum moisture provides direct evidence of the moisturizing effect of ceramide products.

• Measurement conditions: Changes over time are tracked at 30 minutes, 1 hour, 2 hours, 4 hours, and 8 hours after product application.
• Significance threshold: If the Corneometer value is 20% or more higher than the untreated site 4 hours after application, this indicates good moisture retention.

3. Tape stripping method

The stratum corneum is sequentially stripped using adhesive tape, and the ceramide content in the stripped corneocytes is quantified by HPLC (high-performance liquid chromatography) or mass spectrometry. This directly demonstrates that ceramide levels in the stratum corneum increase with continuous use (4–8 weeks) of a ceramide-containing product. This is a research-oriented evaluation method often omitted in standard OEM development, but it is conducted when academic evidence is needed.

4. Skin replica method

A silicone replica of the skin surface is taken and analyzed by image processing to quantify skin texture. This evaluates whether skin texture uniformity improves before and after using a ceramide product. VISIA imaging analysis (Canfield) is also used for similar purposes.

It is a significant advantage if the OEM manufacturer owns these evaluation instruments in-house. Testing can also be outsourced to external laboratories (such as Japan Food Research Laboratories, Nikko Group, or Kirei Test Lab), with costs estimated at ¥300,000–1,000,000 (approx. $2,000–6,700) per test.

The ceramide cosmetics market is highly competitive, and a clear differentiation strategy is essential for OEM development. Here are differentiation approaches from both the formulation design and marketing perspectives.

Formulation-based differentiation

• Five types of human-type ceramides: Formulate all five—EOP, NS, NP, AP, and AG—and position the product as "covering all five major ceramides found in the stratum corneum." Since most competing products contain only 1–2 types, the number of ceramide types is a clear differentiator. Note the balance between formulation levels (0.05–0.2% each) and cost (raw material costs increase 2–3x).
• Lamellar structure technology messaging: Concepts such as "recreating the skin's natural lamellar structure" or "penetrating with the same structure as the stratum corneum" are easy for consumers to understand and have solid technical backing. Using polarized light microscopy images of lamellar structures on packaging and promotional materials enhances messaging impact.
• Ceramide + functional ingredient combinations: Strategic pairing with ingredients that complement ceramide's effects—niacinamide (promotes ceramide synthesis), hyaluronic acid (synergistic moisturizing through a different mechanism), or CICA (centella asiatica extract, combined anti-inflammatory approach).

Story-based differentiation

• Fermented ceramide narrative: Using Takasago's fermented ceramide, build a narrative around "natural-origin ceramide born through biotechnology" and "sustainable manufacturing process." This aligns with the clean beauty and ethical cosmetics trend.
• Japanese rice-derived ceramide: Formulating with Unitika's rice-derived glucosylceramide enables a "skincare born from Japanese rice" story. This can appeal to inbound tourism demand and souvenir markets.
• Evidence-based dermatological approach: Publishing clinical data (TEWL, stratum corneum moisture content) on packaging and the official website builds trust through a "dermatological science approach."

Cost and minimum lot guidelines

Ceramide raw materials are among the higher-priced cosmetic ingredients. Ceramide NP raw material costs approximately ¥50,000–150,000 (approx. $330–1,000) per kg, and Ceramide EOP costs ¥150,000–300,000 (approx. $1,000–2,000) per kg. On a finished product basis (30 mL serum, 0.2% ceramide), for a 3,000-unit lot, the estimated manufacturing cost is ¥300–600 (approx. $2–4) per unit. For formulations with five human-type ceramides, costs increase to approximately ¥500–900 (approx. $3.30–6) per unit. Retail pricing in the ¥3,000–8,000 (approx. $20–53) range is typical, ensuring brand value and healthy profit margins.